Cargando…

Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics

Recombinant protein-based biotherapeutics drugs have transformed clinical pipelines of the biopharmaceutical industry since the launch of recombinant insulin nearly four decades ago. These biologic drugs are structurally more complex than small molecules, and yet share a similar principle for ration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Xiaotian, D’Antona, Aaron M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103270/ https://www.ncbi.nlm.nih.gov/pubmed/33808165 http://dx.doi.org/10.3390/antib10020013

Ejemplares similares

A potential antibody repertoire diversification mechanism through tyrosine sulfation for biotherapeutics engineering and production
por: Zhong, Xiaotian, et al.
Publicado: (2022)

“Stapling” scFv for multispecific biotherapeutics of superior properties
por: Boucher, Lauren E., et al.
Publicado: (2023)

Toward Drug-Like Multispecific Antibodies by Design
por: Sawant, Manali S., et al.
Publicado: (2020)

Recent advances in the treatment of C. difficile using biotherapeutic agents
por: Giau, Vo Van, et al.
Publicado: (2019)

New Opportunities in Glycan Engineering for Therapeutic Proteins
por: Zhong, Xiaotian, et al.
Publicado: (2022)

Tradeoff Between Stability and Multispecificity in the Design of Promiscuous Proteins
por: Fromer, Menachem, et al.
Publicado: (2009)

Advances in the Development of Biotherapeutics
por: Oliveira, Pedro H., et al.
Publicado: (2015)

Recent Advances in the Treatment of C. difficile Using Biotherapeutic Agents [Corrigendum]
Publicado: (2021)

Recent Advances in Assessing Immunogenicity of Therapeutic Proteins: Impact on Biotherapeutic Development
por: Lu, Yanmei, et al.
Publicado: (2016)

Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells
por: Fang, Xiaotian T., et al.
Publicado: (2017)

Multispecific resistance of sheep trichostrongylids in Austria
por: Untersweg, Florian, et al.
Publicado: (2021)

Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer
por: Elshiaty, Mariam, et al.
Publicado: (2021)

The use of CrossMAb technology for the generation of bi- and multispecific antibodies
por: Klein, Christian, et al.
Publicado: (2016)

Biosensors for D-Amino Acids: Detection Methods and Applications
por: Rosini, Elena, et al.
Publicado: (2020)

Next generation Fc scaffold for multispecific antibodies
por: Estes, Bram, et al.
Publicado: (2021)

Retinitis Pigmentosa: Progress in Molecular Pathology and Biotherapeutical Strategies
por: Liu, Wanqin, et al.
Publicado: (2022)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

Multispecific Antibodies: DNA‐Mediated Assembly of Multispecific Antibodies for T Cell Engaging and Tumor Killing (Adv. Sci. 2/2020)
por: Pan, Liqiang, et al.
Publicado: (2020)

Avidity in antibody effector functions and biotherapeutic drug design
por: Oostindie, Simone C., et al.
Publicado: (2022)

Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment
por: Wang, Jiewen, et al.
Publicado: (2022)

Multispecific drugs: the fourth wave of biopharmaceutical innovation
por: Wang, Yifei, et al.
Publicado: (2020)

Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
por: Martin, Kyle P., et al.
Publicado: (2023)

Recent Advances in Single-Cell Profiling and Multispecific Therapeutics: Paving the Way for a New Era of Precision Medicine Targeting Cardiac Fibroblasts
por: Shi, Sally Yu, et al.
Publicado: (2021)

Advancements in Particle Engineering for Inhalation Delivery of Small Molecules and Biotherapeutics
por: Chang, Rachel Yoon Kyung, et al.
Publicado: (2022)

Rigidly connected multispecific artificial binders with adjustable geometries
por: Wu, Yufan, et al.
Publicado: (2017)

Programmable multispecific DNA-origami-based T-cell engagers
por: Wagenbauer, Klaus F., et al.
Publicado: (2023)

Digital signal processing for measurement systems: theory and applications
por: D'Antona, Gabriele, et al.
Publicado: (2006)

The Emerging Biotherapeutic Agent: Akkermansia
por: Kalia, Vipin Chandra, et al.
Publicado: (2021)

Posttranslational Modifications and the Immunogenicity of Biotherapeutics
por: Jefferis, Roy
Publicado: (2016)

Multispecific Substrate Recognition in a Proton-Dependent Oligopeptide Transporter
por: Martinez Molledo, Maria, et al.
Publicado: (2018)

Pediatric Dosing and Body Size in Biotherapeutics
por: Shi, Rong, et al.
Publicado: (2010)

IgY Antibodies as Biotherapeutics in Biomedicine
por: León-Núñez, Diana, et al.
Publicado: (2022)

Engineering Components of the Lactobacillus S-Layer for Biotherapeutic Applications
por: Klotz, Courtney, et al.
Publicado: (2018)

Integrated BioTherapeutics
por: Aman, M. Javad
Publicado: (2018)

Population-specific design of de-immunized protein biotherapeutics
por: Schubert, Benjamin, et al.
Publicado: (2018)

Designer Probiotics: The Next-Gen High Efficiency Biotherapeutics
por: Singh, Birbal, et al.
Publicado: (2019)

Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies
por: Husain, Bushra, et al.
Publicado: (2018)

Recent Advances on the Design and Applications of Antimicrobial Nanomaterials
por: Ortega-Nieto, Clara, et al.
Publicado: (2023)

Machine-designed biotherapeutics: opportunities, feasibility and advantages of deep learning in computational antibody discovery
por: Wilman, Wiktoria, et al.
Publicado: (2022)

Li–Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment
por: Rocca, Valentina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i28q2ohdqrrb7au627ggvbnd71